Microelimination of Hepatitis C in Patients with Substance Use and Dual Disorders - a Portuguese Study

Jpn J Infect Dis. 2024 Sep 19;77(5):269-273. doi: 10.7883/yoken.JJID.2024.056. Epub 2024 May 31.

Abstract

Chronic hepatitis C (CHC) is a serious condition of public health importance. In Portugal, the prevalence of detectable hepatitis C virus (HCV) antibodies is approximately 0.54%, with a higher prevalence in high-risk groups. Compared with the general population, the prevalence of HCV infection is higher in individuals with psychiatric disorders. As no studies have reported the prevalence of HCV antibodies in Portuguese patients with psychiatric conditions and substance use disorders, we conducted an observational, prospective study of patients followed in the Dual Pathology Outpatient and Inpatient Unit of Coimbra Hospital and University Center (CHUC), Patients were tested for HCV antibodies. Of the 149 patients, 17.4% were positive for HCV antibodies and 7.4% had detectable HCV RNA indicating CHC. Most patients with confirmed CHC were male inpatients, aged 50 to 59 years, and reported unprotected sex with more than one concurrent partner in the past 6 months. Their most common psychiatric diagnosis was "Disorders due to use of multiple specified psychoactive substances, including medications." The prevalence of HCV antibodies and confirmed CHC were higher in patients followed in the Dual Pathology Outpatient and Inpatient Unit than in the general Portuguese population.

Keywords: C hepatitis; HCV antibodies; dual disorders; psychiatry; substance use disorder.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Female
  • Hepacivirus / immunology
  • Hepatitis C / epidemiology
  • Hepatitis C Antibodies* / blood
  • Hepatitis C, Chronic* / epidemiology
  • Humans
  • Male
  • Mental Disorders / epidemiology
  • Middle Aged
  • Portugal / epidemiology
  • Prevalence
  • Prospective Studies
  • RNA, Viral / blood
  • Substance-Related Disorders* / complications
  • Substance-Related Disorders* / epidemiology
  • Young Adult

Substances

  • Hepatitis C Antibodies
  • RNA, Viral